[Characteristics of the effect of psychotropic preparations on the synaptosomal uptake of monoamines]. 1985

N I Maĭsov, and E M Gankina, and T A Voronina

The authors investigated the ability of psychotropic drugs of different classes (psychostimulants, antidepressants and tranquilizers) to inhibit the reverse synaptosomal uptake of monoamine neurotransmitters in the rat brain. The psychostimulants amphetamine and cocaine (50 microM) powerfully suppressed noradrenaline, dopamine and serotonin transport without influencing GABA uptake. Phenazepam (50 microM) negligibly decreased the reverse synaptosomal uptake chiefly of noradrenaline. Studies of the antidepressants evidenced that inkazan is a highly selective inhibitor of the reverse uptake of serotonin, whereas other antidepressants such as zimelidine, imipramine and norzimelidine were discovered to inhibit the uptake of serotonin to a larger extent than that of other transmitters. The antidepressants pyrazidol and viloxazine turned out to be non-selective inhibitors of the transport of all monoamines tested. Iproniazide and moclobamide appeared inactive as regards the reverse uptake of monoamine neurotransmitters.

UI MeSH Term Description Entries
D009411 Nerve Endings Branch-like terminations of NERVE FIBERS, sensory or motor NEURONS. Endings of sensory neurons are the beginnings of afferent pathway to the CENTRAL NERVOUS SYSTEM. Endings of motor neurons are the terminals of axons at the muscle cells. Nerve endings which release neurotransmitters are called PRESYNAPTIC TERMINALS. Ending, Nerve,Endings, Nerve,Nerve Ending
D011619 Psychotropic Drugs A loosely defined grouping of drugs that have effects on psychological function. Here the psychotropic agents include the antidepressive agents, hallucinogens, and tranquilizing agents (including the antipsychotics and anti-anxiety agents). Psychoactive Agent,Psychoactive Agents,Psychoactive Drug,Psychopharmaceutical,Psychopharmaceuticals,Psychotropic Drug,Psychoactive Drugs,Agent, Psychoactive,Agents, Psychoactive,Drug, Psychoactive,Drug, Psychotropic,Drugs, Psychoactive,Drugs, Psychotropic
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D003864 Depression, Chemical The decrease in a measurable parameter of a PHYSIOLOGICAL PROCESS, including cellular, microbial, and plant; immunological, cardiovascular, respiratory, reproductive, urinary, digestive, neural, musculoskeletal, ocular, and skin physiological processes; or METABOLIC PROCESS, including enzymatic and other pharmacological processes, by a drug or other chemical. Chemical Depression,Chemical Depressions,Depressions, Chemical
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D000588 Amines A group of compounds derived from ammonia by substituting organic radicals for the hydrogens. (From Grant & Hackh's Chemical Dictionary, 5th ed) Amine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000928 Antidepressive Agents Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. Antidepressant,Antidepressant Drug,Antidepressant Medication,Antidepressants,Antidepressive Agent,Thymoanaleptic,Thymoanaleptics,Thymoleptic,Thymoleptics,Antidepressant Drugs,Agent, Antidepressive,Drug, Antidepressant,Medication, Antidepressant
D013574 Synaptosomes Pinched-off nerve endings and their contents of vesicles and cytoplasm together with the attached subsynaptic area of the membrane of the post-synaptic cell. They are largely artificial structures produced by fractionation after selective centrifugation of nervous tissue homogenates. Synaptosome
D014149 Tranquilizing Agents A traditional grouping of drugs said to have a soothing or calming effect on mood, thought, or behavior. Included here are the ANTI-ANXIETY AGENTS (minor tranquilizers), ANTIMANIC AGENTS, and the ANTIPSYCHOTIC AGENTS (major tranquilizers). These drugs act by different mechanisms and are used for different therapeutic purposes. Ataractics,Tranquilizing Drugs,Tranquilizing Effect,Tranquilizing Effects,Tranquillizing Agents,Tranquillizing Drugs,Agents, Tranquilizing,Agents, Tranquillizing,Drugs, Tranquilizing,Drugs, Tranquillizing,Effect, Tranquilizing,Effects, Tranquilizing

Related Publications

N I Maĭsov, and E M Gankina, and T A Voronina
June 1994, Insect biochemistry and molecular biology,
N I Maĭsov, and E M Gankina, and T A Voronina
July 1984, Biochemical pharmacology,
N I Maĭsov, and E M Gankina, and T A Voronina
October 1983, Journal of neuroscience methods,
N I Maĭsov, and E M Gankina, and T A Voronina
March 1983, Naunyn-Schmiedeberg's archives of pharmacology,
N I Maĭsov, and E M Gankina, and T A Voronina
July 1966, Shinkei kenkyu no shimpo. Advances in neurological sciences,
N I Maĭsov, and E M Gankina, and T A Voronina
April 1979, The Journal of pharmacology and experimental therapeutics,
N I Maĭsov, and E M Gankina, and T A Voronina
January 1976, Biulleten' eksperimental'noi biologii i meditsiny,
N I Maĭsov, and E M Gankina, and T A Voronina
November 1992, Biulleten' eksperimental'noi biologii i meditsiny,
N I Maĭsov, and E M Gankina, and T A Voronina
January 1980, Neurochemical research,
N I Maĭsov, and E M Gankina, and T A Voronina
January 1988, Farmakologiia i toksikologiia,
Copied contents to your clipboard!